Pharmaceutical Selling

Team Leader at Prime Minister's Performance Delivery Unit, Pakistan à Prime Minister's Performance Delivery Unit, Pakistan
20 Jan 2013
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
Pharmaceutical Selling
1 sur 88

Contenu connexe

Tendances

 basic selling skills 1 basic selling skills 1
basic selling skills 1Mostafa Elrefaiy
selling skills pharmaceuticalselling skills pharmaceutical
selling skills pharmaceuticalSHAHID LATIF
Pharmaceutical sellingPharmaceutical selling
Pharmaceutical sellingSalah35
Advanced selling skills p3Advanced selling skills p3
Advanced selling skills p3Mohammed Gamal
Sales ppt training and develop in pharma industrySales ppt training and develop in pharma industry
Sales ppt training and develop in pharma industryshumaila91
Things to do before making doctor callsThings to do before making doctor calls
Things to do before making doctor callsKaustubh Agarwal

En vedette

DetailingDetailing
DetailingShilpa Garg
2015 Pharmaceutical Sales Rep Experience 2015 Pharmaceutical Sales Rep Experience
2015 Pharmaceutical Sales Rep Experience GSW
Qualities of a good Medical RepresentativeQualities of a good Medical Representative
Qualities of a good Medical RepresentativeDebojite Bhowmick
Pharmaceutical detailing and relationship selling skill trainingPharmaceutical detailing and relationship selling skill training
Pharmaceutical detailing and relationship selling skill trainingMohammad Masum Chowdhury
Implementing New Approach to Pharmaceutical SellingImplementing New Approach to Pharmaceutical Selling
Implementing New Approach to Pharmaceutical Sellingteleosconsulting
Awais e Siraj CVAwais e Siraj CV
Awais e Siraj CVAwais e Siraj

Similaire à Pharmaceutical Selling

SPI Insight: Taking the Pulse of Big Changes in Healthcare SalesSPI Insight: Taking the Pulse of Big Changes in Healthcare Sales
SPI Insight: Taking the Pulse of Big Changes in Healthcare SalesDario Priolo
Towards Value Innovation In Pharma SFE Conference London 062007Towards Value Innovation In Pharma SFE Conference London 062007
Towards Value Innovation In Pharma SFE Conference London 062007A.R.J. (Rob) Halkes
Nauman CVNauman CV
Nauman CVNauman Adil
Marketing Techniques for Health System/Hospital-Based Retail Health ClinicsMarketing Techniques for Health System/Hospital-Based Retail Health Clinics
Marketing Techniques for Health System/Hospital-Based Retail Health ClinicsLegato Marketing & Communications
Suzanne Hendery Branding Case Study for Renown Health.pptxSuzanne Hendery Branding Case Study for Renown Health.pptx
Suzanne Hendery Branding Case Study for Renown Health.pptxSuzanne Hendery
jenny johnson resume updatejenny johnson resume update
jenny johnson resume updateJenny Johnson RN, BSN

Plus de Awais e Siraj

Performance contractsPerformance contracts
Performance contractsAwais e Siraj
Balanced Scorecard for a Non-Profit OrganizationBalanced Scorecard for a Non-Profit Organization
Balanced Scorecard for a Non-Profit OrganizationAwais e Siraj
Kpi es facilitator awaisKpi es facilitator awais
Kpi es facilitator awaisAwais e Siraj
SM & BSC NTDCSM & BSC NTDC
SM & BSC NTDCAwais e Siraj
Beetle VW Volkswagen Restoration StoryBeetle VW Volkswagen Restoration Story
Beetle VW Volkswagen Restoration StoryAwais e Siraj
Balanced Scorecard Vision 2025 PakistanBalanced Scorecard Vision 2025 Pakistan
Balanced Scorecard Vision 2025 PakistanAwais e Siraj

Dernier

2012-2017: NTN Groundbreaking Ceremonies in North America2012-2017: NTN Groundbreaking Ceremonies in North America
2012-2017: NTN Groundbreaking Ceremonies in North AmericaTETSUYA SOGO
ResumeResume
ResumeAnthoneyHuff
WHY for Rotary 2023.09.20.08.56.pptxWHY for Rotary 2023.09.20.08.56.pptx
WHY for Rotary 2023.09.20.08.56.pptxPaul Menig
TSX-V_WIL_2021-DATA.KRESTON.VN.pdfTSX-V_WIL_2021-DATA.KRESTON.VN.pdf
TSX-V_WIL_2021-DATA.KRESTON.VN.pdfThuPhng26102
Online Giving Trends (3).pdfOnline Giving Trends (3).pdf
Online Giving Trends (3).pdfBloomerang
Biotech Fundraising in a DownturnBiotech Fundraising in a Downturn
Biotech Fundraising in a DownturnVolker Hirsch

Pharmaceutical Selling

Notes de l'éditeur

  1. Consider your objective for the call. Is it clear cut? Is it consistent with the priorities of the division? Is it S.M.A.R.T? Finally, what can you offer that is of interest to the customer to support both your objectives and his/her needs.
  2. What are you trying to accomplish in the sales call?
  3. Ask: “How many of you know what a strategic Map is? Of those of you who raised your hand, can you identify off the top of your head the priorities your MM or BUM has listed on your specific divisional country strategic map? If we pursue the tactics our Marketing Manager has given us the direction to pursue, are we prepared to support them? Do we have the proper currencies to support such an endeavor? We will discuss in a moment the important role of “value-adds.”
  4. Why is a S.M.A.R.T objective?
  5. Ask: “Who can tell me what a value-add is?” As a business consultant, Boston Scientific offers many programs and areas of support which are in line with the customer ’s interest – you just need to identify the match.
  6. Some of the support we can offer comes in the form of the sales tool. When we spend time in the field, we should evaluate whether our Territory Managers are utilizing the most current and effective tools available. Also, be honest with yourself; how many Territory Managers are bringing a complete bag into every call? If they are not using one when they are with you, then how under prepared are they when working alone?
  7. Welcome to the selling process segment of the Boston Scientific International Sales Model, “ASK.” The medical drug industry as we see it today is both highly competitive and constantly changing. In order to keep up with the frequent demands of the sales representative ’s daily activities, our field-based team must be fully prepared to confidently and consistently address the uppermost needs of the customer. Without identifying a true “need,” the long-term commitment from the customer will never take root.
  8. A successful rep is able to establish the clinical need by first uncovering a weakness, or shortcoming, in the clinician ’s current modality. At this point, although a need is established, customer commitment is not obtained until the clinician believes that Boston Scientific offers a viable solution to this newly discovered necessity. Later in the program we will spend time on how to successfully establish and address this clinical or technical need.
  9. In the ASK model, there are 6 steps to a successful sales call.
  10. Strong opening.
  11. Probing questions – quite frankly something we don ’t do enough of.
  12. reinforcing.
  13. Offering a solution.
  14. Offering a solution.
  15. And finally, gaining a commitment from the customer. During this segment we will discuss the ways to confirm whether or not the commitment is one we can depend on or if it is simply a statement from the customer implying: “I’ll try it for a while.”
  16. It is important to recognize that no step can be skipped to obtain a true commitment. At the end of this program if you and your team were to look back at your discussion and discuss which step you felt is most critical, there would most likely be mixed opinions, which clearly indicates that no step is un important.
  17. Ask: “What defines a strong opening? Consider what you have seen or used that works and what has not in your reply.” The Territory Manager must recognize that without a strong opening, the conversation can come to an abrupt halt. If the customer does not see the benefit in continuing the conversation, you will never hold their attention long enough to gain a sustainable commitment in the long run.
  18. Ask the group: “What is reinforcing?” Let them take their time in replying. You will get anything between a quiet room and mixed opinions. This is typically the step of the selling process TMs struggle with the most. The most successful reps are able to implicate in a professional way. Remember, you are not looking to correct their current choice of treatment as much as uncover a possible “better way” of approaching a disease. All physicians are interested in improving outcomes, but you need to be careful in your approach when you implicate.
  19. Now that you have reviewed examples, to emphasize the importance of this step of the selling process, take some time discussing how critical it is to effectively implicate. reinforcing is how we establish the need . Everything before simply sets it up, while everything after is nothing more than “fixing” the identified problem.
  20. “ Now that we have successfully implicated, it is time to offer a solution. What does the solution statement accomplish?” The most important point of this slide is the last one. The solution statement gives us the right to show a product (or introduce a program). Too many times the TM holds the product in their hands during the previous 3 steps (opening, probing and reinforcing). When they do this, the customer is looking at the drug, without giving any attention to the conversation. In a situation like this, the customer will typically make their decision before we even have the opportunity to probe.
  21. Regarding the need, we need to discuss the difference between an “implied need” and an “explicit need.” There is a big difference between the two, and although an implied need may lead to a purchase order, only the explicit need leads to repeat orders – the true indication that the customer has converted.
  22. Immediately after an unsuccessful sales call, a smart sales rep learns from a bad experience by considering the following: “ How do I feel about the call?” “ How effective was my plan?” “ Did I accomplish or advance my call objective?” “ What went well that I should keep – or reinforce?” “ What didn’t go well that I should change?” “ What is the next step with this customer?” These questions will help us learn from our mistakes and better prepare us for the next face-to-face visit with a given customer.
  23. Ask; “What are we hearing out there as far as customer objections go?” Answers will come readily from the participants with those listed on this slide being some of them.
  24. Walk the participants through the 4-step process.
  25. After submitting this secondary solution – that which addresses the objection to our first solution – we now need to confirm that the customer is no longer hesitant to commit. Suggesting the next step of action will certainly accomplish this.
  26. Since we are dealing with a customer who has objected at least once, this slide is one you need to spend some time on. Customers who did not agree to your first suggested solution may not still be ready to commit. If the sales force believes that they have addressed all objections and the customer is ready to commit, they can “test the water” with a trial close.
  27. With an agreement to the trial close, the sales rep has successfully achieved the customer ’s full commitment and a hard close is now in order.
  28. An example of a hard close. It may seem like we are asking for a lot in this particular example, but if the rep has truly addressed all objections, it is both necessary (and appropriate) to ask for a full commitment.
  29. Welcome to the final stage of the ASK Sales Model – Retaining the Business. The competitive landscape in today ’s medical industry is extremely challenging, and with that, business can be lost as fast as it is gained. For any Sales Representative just joining the company (and obviously new to their territory), the first priority is to protect the business we currently have while the second priority is to gain new business. This workshop offers suggestions on how to best accomplish both.
  30. Walk the group of attendees through this series of questions. Do they see a difference between the methods used to gain new business and those used to protect current business? There should be a lot of similarities between each. Ask the room: “What do we mean by ‘mind share’?” Mind share is the definition of how quickly, how often, and how passionately Boston Scientific comes to mind when the customer is asked the following question: “Who is the leading supplier of minimal invasive drugs in your field?” Be sure to emphasize that when managing a territory, the cost of gaining a new customer is significantly higher than the cost of maintaining current business.
  31. Ask: “What are some of things we do today to help protect our current base business while ensuring that new business “sticks?” Some refer to the regular practice of these habits as “installing” a product. Installing a product is nothing more than conducting the everyday tasks that support continued and successful use of a drug within the account.
  32. Conducting in-services. In-servicing the customer is critical when installing a new drug. Anyone involved in a procedure when a new technology is introduced needs to fully understand what their responsibility is. To ensure a successful transition to a new technology, it is sometimes best to make ourselves available for the first few cases. Now, regarding existing business, ask the group: “What is at risk if we don’t re-visit older technologies when scheduling in-services?” Hospital staff can become unfamiliar with a drug if it is not used on a regular basis. On-going educational programs will help prevent this.
  33. Proper inventory is critical. Express to the sales force that after all the work they have done, the last thing they need to see is limited drug usage because of a lack of appropriate inventory on hand. Each end user has his/her specific sizes they prefer. These product codes must be identified to ensure availability at the time of the procedure. Also, it is important to identify who keeps inventory and places order requests with materials management. These individuals need to be well informed. As far as competitive inventory is concerned, knowing how much is on hand and who uses it will help determine account penetration and whether this inventory poses a threat to usage of specific BSC drugs.
  34. Discuss with the team the importance of pricing by reviewing each point above. If the customer sees your drug as a premium (clinically or technically) then charging a higher price should be justifiable – but you may still need to confirm their acceptance. Briefly discuss contracts and bundling as they pertain to the local marketplace. Both can be used to leverage and protect business if done properly.
  35. This slide uncovers a major mistake even the veteran rep can make – staying content with a customer using an old generation technology due to the mindset of: “As long as they’re happy, I’m happy. Besides, I still do have the business.” This mistake opens the door for the competition to steal your business with today’s technology. Stress how keeping all customers abreast of current developments in technology will best prevent the competition from sneaking in where we least expect it.
  36. Regular conversation on the effectiveness of BSC drugs the clinician is currently using will reconfirm why the customer ever committed to BSC in the fist place. This “soft sell” approach may take only a few seconds to do, but will strongly re-establish our position in the marketplace as the industry leader.
  37. Finally, reaching outside the comfort zone of your everyday lab to seek out additional end users is a great way to increase overall drug usage in a given account. Ask yourself: “Who else would benefit from this technology based on the patients they treat?” Use the success of your current users within the same account as third-party references.